These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 685996)
21. [Vasodilator agents in the treatment of heart failure]. Prati PL; Manfrin M G Ital Cardiol; 1978; 8(1):1-11. PubMed ID: 415927 [No Abstract] [Full Text] [Related]
22. Vasodilative effect of hydralazine in awake dogs: the roles of prostaglandins and the sympathetic nervous system. Maekawa K; Liang CS; Tsui A; Chen BT; Kawashima S Circulation; 1984 Nov; 70(5):908-16. PubMed ID: 6488504 [TBL] [Abstract][Full Text] [Related]
23. Peripheral vasodilators in the treatment of cardiac failure. Forrester JS; da Luz PL Adv Cardiol; 1976; 17():123-32. PubMed ID: 818884 [No Abstract] [Full Text] [Related]
24. [New aspects in the treatment of acute cardiac insufficiency]. Sterz H Wien Med Wochenschr; 1978 May; 128(9):256-61. PubMed ID: 27016 [No Abstract] [Full Text] [Related]
25. Preload and afterload without anguish: a simplified framework. Mandell HN; Deglin SM Postgrad Med; 1982 May; 71(5):105-12. PubMed ID: 6803231 [No Abstract] [Full Text] [Related]
26. [Treatement of circulatory insufficiency with vasodilator agents]. Chazov EI; Ruda MIa Kardiologiia; 1979 Aug; 19(8):15-7. PubMed ID: 114704 [No Abstract] [Full Text] [Related]
27. [Treatment of cardiac failure with vasodilators (author's transl)]. Imhof P Schweiz Rundsch Med Prax; 1978 May; 67(22):219-29. PubMed ID: 418395 [No Abstract] [Full Text] [Related]
28. [Continuous flow vasodilator perfusion treatment in the acute phase of myocardial infarct]. Prasquier R; Fruchaud J; Gourgon R Anesth Analg (Paris); 1977; 34(6):1281-5. PubMed ID: 613879 [No Abstract] [Full Text] [Related]
30. Contributions of hemodynamic monitoring to the treatment of chronic congestive heart failure. Armstrong PW Can Med Assoc J; 1979 Oct; 121(7):913-8. PubMed ID: 497982 [TBL] [Abstract][Full Text] [Related]
31. Differential systemic arterial and venous actions and consequent cardiac effects of vasodilator drugs. Miller RR; Fennell WH; Young JB; Palomo AR; Quinones MA Prog Cardiovasc Dis; 1982; 24(5):353-74. PubMed ID: 6801728 [No Abstract] [Full Text] [Related]
32. [Vasodilator agents in the therapeutic arsenal of cardiac insufficiency]. Lavitola Pde L; Higa SS Rev Paul Med; 1986; 104(3):136-40. PubMed ID: 3563266 [No Abstract] [Full Text] [Related]
33. Congestive heart failure. Ruggie N Med Clin North Am; 1986 Jul; 70(4):829-51. PubMed ID: 3012226 [TBL] [Abstract][Full Text] [Related]
35. Provocation of myocardial ischemic events during initiation of vasodilator therapy for severe chronic heart failure. Clinical and hemodynamic evaluation of 52 consecutive patients with ischemic cardiomyopathy. Packer M; Meller J; Medina N; Yushak M; Gorlin R Am J Cardiol; 1981 Nov; 48(5):939-46. PubMed ID: 7304442 [TBL] [Abstract][Full Text] [Related]
36. Vasodilator therapy of cardiac failure: (first of two parts). Cohn JN; Franciosa JA N Engl J Med; 1977 Jul; 297(1):27-31. PubMed ID: 405585 [No Abstract] [Full Text] [Related]
37. Comparison of haemodynamic effects of phentolamine, sodium nitroprusside, and glyceryl trinitrate in acute myocardial infarction. Kötter V; von Leitner ER; Wunderlich J; Schröder R Br Heart J; 1977 Nov; 39(11):1196-204. PubMed ID: 412507 [No Abstract] [Full Text] [Related]
38. Symposium on vasodilator and inotropic therapy of heart failure. Symposium perspective. Mason DT Am J Med; 1978 Jul; 65(1):101-5. PubMed ID: 356597 [No Abstract] [Full Text] [Related]